Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
HAS
Description:
The third-person singular present-tense form of the English verb “have,” studied in grammar and language education.
Primary topic:
Health Systems, Economic Evaluations, Quality of Life (36%)
Related topics:
Health Systems, Economic Evaluations, Quality of Life (36%),
Pharmaceutical Economics and Policy (14%)
OpenAlex ID:
keywords/has
Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries
2016
·
Elena Nicod
·
The European Journal of Health Economics
·
101
PDF
Mammalian hyaluronan synthases: investigation of functional relationships in vivo
1999
·
A. P. Spicer
, T. K. Nguyen
·
Biochemical Society Transactions
·
81
Utilisation des opioïdes forts dans la douleur chronique non cancéreuse chez l’adulte. Recommandations françaises de bonne pratique clinique par consensus formalisé (SFETD)
2016
·
Xavier Moisset
, Anne-Priscille Trouvin
, et al.
·
La Presse Médicale
·
72
Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden
2009
·
Ruth Schwarzer
, Uwe Siebert
·
International Journal of Technology Assessment in Health Care
·
66
Adaptive Splines and Genetic Algorithms
2002
·
Jennifer Pittman
·
Journal of Computational and Graphical Statistics
·
56
A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments
2015
·
Marc Massetti
, Samuel Aballéa
, et al.
·
Journal of Market Access & Health Policy
·
45
PDF
The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system
2018
·
Akram Assali
, Shayan Razzazan
, et al.
·
Colloids and Surfaces B Biointerfaces
·
43
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
2020
·
Rick A. Vreman
, Lourens T. Bloem
, et al.
·
International Journal of Health Policy and Management
·
30
PDF
Development of health technology assessment in France
2009
·
Caroline Weill
, David Banta
·
International Journal of Technology Assessment in Health Care
·
28
PDF
Type 2 diabetes treatment: French recommendations for good practice AFSSAPS - HAS.2006.
2006
·
PubMed
·
28
French hip resurfacing registry: A study of 1650 cases
2021
·
Julien Girard
, Jean Alain Epinette
, et al.
·
Orthopaedics & Traumatology Surgery & Research
·
23
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France
2022
·
Christophe Roussel
, Olivier Chassany
, et al.
·
Therapies
·
22
PDF
Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma
2012
·
Anil Kumar Tomar
, Balwinder Singh Sooch
, et al.
·
International Journal of Biological Macromolecules
·
22
In vitro effects of Apixaban on 5 different cancer cell lines
2017
·
Luigina Guasti
, Alessandro Squizzato
, et al.
·
PLoS ONE
·
18
PDF
Health technology assessment of medical devices
2018
·
Paweł Kawalec
, Magdalena Mrożek-Gąsiorowska
, et al.
·
Zdrowie Publiczne i Zarządzanie
·
16
PDF
The Role of crumbs Genes in the Vertebrate Cornea
2010
·
Jill Beyer
, Xinping C. Zhao
, et al.
·
Investigative Ophthalmology & Visual Science
·
16
PDF
Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells
2022
·
Theodoros Karalis
, Andrew Shiau
, et al.
·
Cancers
·
13
PDF
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process
2023
·
Hugo Larose
, Myrto Lee
, et al.
·
Health Research Policy and Systems
·
10
PDF
Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies
2022
·
Entela Xoxi
, Rossella Di Bidino
, et al.
·
Frontiers in Medical Technology
·
9
PDF
Relativistic and correlation effects on spectroscopic constants of the hydrogen astatide molecule
2003
·
Jacek Styszyński
, Jacek Kobus
·
Chemical Physics Letters
·
9
PD45 Paying For Digital Health: What Evidence Is Needed?
2022
·
Anita Burrell
, Vlad Zah
, et al.
·
International Journal of Technology Assessment in Health Care
·
8
PDF
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France
2022
·
Christophe Roussel
, Olivier Chassany
, et al.
·
Therapies
·
8
PDF
Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies: The Case of Multiple Myeloma and PCSK9S
2016
·
A Jaksa
, D Liden
·
Value in Health
·
8
Lessons for Adaptive Licensing: Analysis of Conditionally Approved EMA Compounds, Their Reimbursement Status and Regulatory/Reimbursement Data Requirements
2014
·
P.A. Spearpoint
, C.Y. Yip
, et al.
·
Value in Health
·
8
PDF
Intuitionistic Completeness and Classical Logic
2002
·
D. C. McCarty
·
Notre Dame Journal of Formal Logic
·
8
PDF
Show more works
View as search
Works count:
300
Citation count:
931
Year
Topic
Type